Kim Treanor's blogs

NGOs and patient groups call upon Chilean President, Minister of Health to issue a compulsory license for cancer and Hepatitis drugs

FOR IMMEDIATE RELEASE Contact: Kim Treanor kim.treanor@keionline.org; 202-332-2670 Patient groups, civil society and concerned individuals from Chile and around the world call upon President Michelle Bachelet Jeria and Dr. Carmen Castillo Taucher, Minister of Health, to issue a compulsory license for patents on HCV and prostate cancer medicines. A letter signed by these groups and …

Add new comment Read more

NIH Director Dr. Francis Collins falsely asserts Bayh-Dole safeguards do not address excessive pricing abuses

In a hearing before the House Energy & Commerce Subcommittee on Health, Dr. Francis Collins, Director of the National Institutes of Health, explained the agency’s position on the Bayh-Dole rights and high drug prices. In the hearing, focused on the implementation of the 21st Century Cures Act, Representative Jan Schakowsky (D-IL-9) questioned Collins on the …

Add new comment Read more

NIH non-response response to KEI and MSF comments on the proposed exclusive license of Zika vaccine patents to PaxVax

On November 30, 2017, KEI has received a response from the National Institute of Allergy and Infectious Diseases regarding our previous joint comments with MSFon the proposed exclusive license of Zika vaccine technology to PaxVax. The original joint comments from KEI and Médecins Sans Frontières (MSF) contained twelve pages of questions and concerns, while a separate submission …

Add new comment Read more

Statement of Knowledge Ecology International – WHO EB Special session on the draft Thirteenth General Programme of Work

Meeting: EB Special session on the draft Thirteenth General Programme of Work Agenda Item: 3. Draft Thirteenth General Programme of Work Statement: KEI welcomes the opportunity to comment on the 13th General Programme of Work anchored upon WHO’s vision of achieving universal health coverage. The key to achieving universal health coverage is to reduce reliance …

Add new comment Read more

KEI and MSF release comments on the proposed license of Zika vaccine candidates to PaxVax

Background: The National Institutes of Health has proposed giving an exclusive license for multiple Zika vaccine candidates to PaxVax, a company with close ties to the federal government. The NIH-owned vaccine technologies are different from the Zika vaccine candidate the U.S. Army had proposed licensing to Sanofi. In the Sanofi/Army case, when BARDA withdrew funding …

Add new comment Read more

Following KEI request for investigation, Cold Spring Harbor Labs says 7 patents require correction to disclose federal funding

Summary:

  • After KEI filed a complaint with the NIH, Cold Spring Harbor Laboratory (CSHL) corrected a failure to disclose funding of at least 7 patented inventions, including one patent for the drug Sprinraza.
  • Since 2012, when federal funding was relevant to an invention, CSHL failed to make a disclosure on a filed patent more than half the time.
Add new comment Read more

US Federal rights in patents on Probuphine, to treat opioid addiction

Probuphine is an expensive medication used to treat opioid dependence by providing maintenance treatment and lessening withdrawal symptoms. The U.S. federal government also has considerable leverage over the pricing of this product, because of the federal funding of the the research that lead to the sole Orange Book patent on the product, and phase 3 trials that were used the register the product.

Add new comment Read more

Workshop: Patents, the Public Interest and Two New Medical Technologies: CRISPR and CAR T

Workshop: Patents, the Public Interest and Two New Medical Technologies: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Chimeric Antigen Receptors (CAR) technologies

On September 15th, 2017, Knowledge Ecology International will be hosting a workshop on: “Patents, the Public Interest and Two New Medical Technologies: CRISPR and CAR T.”

If you are unable to attend in person, a livestream of the event will be available here

Add new comment Read more

KEI initial comments on NIH proposed grant of exclusive license on liver cancer treatment to Salubris

On August 8, 2017, Knowledge Ecology International (KEI) submitted comments on the proposed grant of an exclusive license from the National Institutes of Health (NIH) and Department of Health and Human Services (HHS) to Salubris Biotherapuetics, Inc, a corporation headquartered in Guangdong, China, for an important new technology that could be used

Add new comment Read more

KEI and Médecins Sans Frontières propose contractual terms to protect access and affordability of Zika vaccine

25 July 2017
FOR IMMEDIATE RELEASE
CONTACT: Kim Treanor, kim.treanor@keionline.org or +1 (202) 332-2670

Washington, 25 July 2017 – Knowledge Ecology International (KEI) and Médecins Sans Frontières (MSF) have sent a letter today to the Command Judge Advocate of the U.S. Army Medical Research and Materiel Command (USAMRMC), recommending two specific contractual terms for the proposed license of the US Army’s Zika vaccine technology to Sanofi Pasteur.

Add new comment Read more